Industrial Biotechnology Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 45.0 billion
Estimated Base Value
2035 Forecast
US$ 97.2 billion
Projected Market Value
CAGR 2026–2035
8.0%
Compound Annual Growth
Largest Segment
Biofuels
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
Asia Pacific
Fastest Growing Region
Middle East & Africa
Top Country
United States
By Market Share
Largest market
Key Players
Novozymes A/S
Emerging Players
Arzeda, Cemvita Factory
Industrial Biotechnology Market Overview
The Industrial Biotechnology Market applies biological systems and organisms to produce industrial goods. This includes the sustainable production of bio-based chemicals, advanced materials, and biofuels. Key processes involve fermentation, biocatalysis, and metabolic engineering, converting renewable biomass into high-value chemicals, polymers, and energy. This market serves various industries seeking sustainable manufacturing and reduced environmental impact. Buyers include companies in the chemical, food and beverage, pharmaceutical, energy, textile, and waste management sectors.
The Industrial Biotechnology Market is estimated at $45.0 Bn in 2025 and is forecast to reach $97.2 Bn in 2035, growing at a CAGR of 8.0% from 2025 to 2035. Demand is driven by strict environmental regulations, consumer preference for eco-friendly products, and technological innovations that reduce production costs. However, high initial investment costs and competition from established petrochemical processes present challenges to market expansion.
The market is segmented by Type (Biofuels, Biochemicals, Industrial Enzymes, Biomaterials, Bio-Based Food & Feed Ingredients), Technology (Recombinant Deoxyribonucleic Acid Technology, Fermentation Technology, Biocatalysis & Enzyme Engineering, Metabolic Engineering, Synthetic Biology, Process Integration & Biorefinery Concepts), Application (Chemicals & Materials, Food & Beverages, Feed, Bioenergy, Pulp & Paper, Textiles, Water & Wastewater Treatment, Personal Care & Cosmetics), Source (Agricultural Feedstocks, Lignocellulosic Biomass, Waste Streams, Algae, Methane & Carbon Dioxide, Vegetable Oils & Fats), End-User (Chemical & Petrochemical Industry, Food & Beverage Industry, Pharmaceutical & Healthcare Industry, Energy & Biofuels Industry, Textile Industry, Pulp & Paper Industry, Waste Management & Environmental Services, Animal Feed Industry), and Process (Microbial Fermentation, Enzymatic Biotransformation, Cell Culture Technology, Biorefinery Integration, Biomass Pretreatment, Downstream Processing Operations). It is served across Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Leading companies include Novozymes A/S, Corbion, Roquette Frères, POET, Gevo, LanzaTech Global, Inc., Amyris, Genomatica, Codexis, AvantGuard, Danimer Scientific, and Origin Materials. The full report provides detailed analysis of these segments and regions.
Market Definition & Overview
The Industrial Biotechnology Market, within the Chemicals & Materials sector, leverages biological systems, organisms, or derivatives (e.g., enzymes, microorganisms) to produce industrial products and processes. This encompasses the sustainable production of bio-based chemicals, advanced materials, biofuels, and other industrial goods. It focuses on processes like fermentation, biocatalysis, and metabolic engineering to convert renewable biomass into high-value chemicals, polymers, and energy carriers, driving sustainable manufacturing and reducing environmental impact across various industrial applications.
Scope
- Global market analysis across key regions and countries
- Segmentation by product type, application, and end-use industry
- Market sizing and forecast from 2025 to 2035
Inclusions
- Bio-based chemicals manufacturing (e.g., succinic acid, lactic acid)
- Bioplastics and bio-polymers production
- Industrial enzymes utilized in chemical processes
- Biofuels for industrial applications
- Biomass conversion technologies for chemical feedstocks
- Biocatalysis and fermentation processes for material synthesis
Exclusions
- Traditional petroleum-based chemical production
- Biotechnology exclusively for pharmaceutical or medical uses
- Food and beverage biotechnology focused on direct human consumption
- Agricultural biotechnology for crop improvement
- Biotechnology research activities not directly linked to industrial production
Market Size Forecast
Executive Summary
• The Industrial Biotechnology market is valued at $45.0 Bn in 2025 and is forecast to reach $97.2 Bn by 2035, reflecting a robust CAGR of 8.0% as demand accelerates across every major segment and region over the ten-year outlook.
• Biofuels leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at XX.X%, while Emerging Areas is expanding the fastest at a XX.X% CAGR, signalling where future growth is shifting.
• China remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intensifying competitive landscapes and strategic consolidation among bio-based chemical producers are reshaping market leadership, driven by economies of scale and intellectual property acquisition across key application segments globally.
• Advancements in synthetic biology and innovative fermentation technologies are unlocking new sustainable production pathways, significantly accelerating market penetration for bio-based alternatives in diverse industrial sectors worldwide.
• Evolving global regulatory frameworks, particularly in Europe and Asia, increasingly favor bio-based products through targeted incentives and mandates, spurring regional investment and shaping adoption trends significantly.
• Significant capital investments are flowing into upstream feedstock diversification and downstream processing infrastructure, addressing supply chain vulnerabilities and enhancing scalability for bio-industrial production across continents.
• The expanding versatility of enzymatic catalysts and microbial platforms is driving novel material development and process efficiencies, positioning the market for continued innovation and sustained long-term expansion.
• Strategic partnerships and cross-sector collaborations are critical for overcoming commercialization hurdles and accelerating market entry for novel bio-based solutions, particularly in emerging high-value applications.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Value
The industrial biotechnology market was valued at $45.0 billion in the base year, indicating a strong foundation for future expansion.
Future Market Projection
This market is projected to achieve a substantial valuation of $97.2 billion by the forecast year, highlighting significant growth potential.
Robust Growth Outlook
The industrial biotechnology market is anticipated to expand at an impressive Compound Annual Growth Rate (CAGR) of 8.0% over the forecast period.
Significant Market Expansion
Overall market expansion is substantial, with the sector growing from $45.0 billion in the base year to a projected $97.2 billion by the forecast year at a 8.0% CAGR.
Regional Leadership
North America is expected to emerge as a leading region, driven by robust R&D activities and early adoption of biotechnological innovations.
Sustainable Product Trend
A notable trend is the escalating demand for sustainable, bio-based products and processes across various industrial applications, fueling market innovation and adoption.
Market Dynamics
Market Trends
- Increasing focus on sustainable production methods.
- Widespread adoption of synthetic biology tools.
- Growing demand for bio-based chemicals.
- Rapid advancements in enzyme engineering.
Growth Drivers
- Strict environmental regulations push adoption.
- Consumer preference for eco-friendly products.
- Technological innovations reduce production costs.
- Need for energy-efficient manufacturing processes.
Restraints
- High initial investment costs hinder widespread adoption and market entry.
- Competition from established petrochemical processes remains a significant challenge.
- Stringent regulatory frameworks and public acceptance issues pose hurdles.
- Scaling up bioprocesses from lab to industrial production is often complex.
Opportunities
- New applications in sustainable biofuels emerge.
- Development of advanced bioplastics and biomaterials.
- Bioremediation solutions address environmental pollution.
- Expanding into bio-based pharmaceutical production.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | BiofuelsBiochemicalsIndustrial EnzymesBiomaterialsBio-Based Food & Feed Ingredients |
| By Technology | Recombinant Deoxyribonucleic Acid TechnologyFermentation TechnologyBiocatalysis & Enzyme EngineeringMetabolic EngineeringSynthetic BiologyProcess Integration & Biorefinery Concepts |
| By Application | Chemicals & MaterialsFood & BeveragesFeedBioenergyPulp & PaperTextilesWater & Wastewater TreatmentPersonal Care & Cosmetics |
| By Source | Agricultural FeedstocksLignocellulosic BiomassWaste StreamsAlgaeMethane & Carbon DioxideVegetable Oils & Fats |
| By End-User | Chemical & Petrochemical IndustryFood & Beverage IndustryPharmaceutical & Healthcare IndustryEnergy & Biofuels IndustryTextile IndustryPulp & Paper IndustryWaste Management & Environmental ServicesAnimal Feed Industry |
| By Process | Microbial FermentationEnzymatic BiotransformationCell Culture TechnologyBiorefinery IntegrationBiomass PretreatmentDownstream Processing Operations |
Regional Analysis
- North America leads the industrial biotechnology market due to its robust research and development infrastructure, significant investments in bio-based products, and early adoption of biotechnological processes. Strong government funding and corporate R&D expenditures in the region contribute to its market dominance.
- Asia Pacific is the fastest-growing region, driven by rapid industrialization, increasing demand for sustainable solutions, and rising environmental awareness. Supportive government policies and expanding manufacturing sectors fuel the adoption of industrial biotechnology across diverse applications.
- Europe shows a significant trend towards circular economy principles and bio-based industrial policies. Strict environmental regulations and ambitious sustainability targets are driving substantial investments into renewable resources and greener manufacturing processes, fostering a robust bioeconomy.
| Asia PacificXX.X% | North AmericaXX.X% | EuropeXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A mature market characterized by significant R&D investments, advanced infrastructure, and a strong drive towards sustainability.
- Key applications include bio-based fuels and specialty chemicals.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Growth in this region is propelled by abundant biomass resources, particularly in Brazil for bioethanol production, and increasing industrial investment in sustainable processes across various sectors.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Driven by stringent environmental regulations and a focus on circular economy principles, Europe is a major hub for innovation in bio-plastics, enzymes, and bio-based materials, with strong academic and industrial collaboration.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- This region dominates the market due to robust industrial growth, increasing adoption of bio-based processes in chemical manufacturing, and strong government support for sustainable technologies, especially in China and India.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Though starting from a smaller base, the region is witnessing increasing interest in bio-based solutions for water treatment, agriculture, and sustainable energy, driven by diversification efforts and environmental concerns.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The U.S. leads in R&D and commercialization of industrial biotechnology, driven by significant investments in biofuels, bio-based chemicals, and industrial enzymes. Strong government support and a robust venture capital ecosystem fuel innovation and market growth. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | Brazil is a global leader in sugarcane ethanol production, a major application of industrial biotechnology. Its strong agricultural base provides abundant feedstock, driving growth in bio-based chemicals, bioplastics, and industrial enzymes. |
| 3 | Germany | US$ XX.X Mn | XX.X% | Germany is a European leader in industrial biotechnology, characterized by strong R&D, substantial government funding, and close collaboration between academia and industry. It excels in developing advanced industrial enzymes, biochemicals, and bio-based materials. |
| 4 | China | US$ XX.X Mn | XX.X% | China is the largest and fastest-growing market for industrial biotechnology, driven by massive investments in bio-based production to enhance sustainability and reduce petrochemical reliance. It is a major producer of biofuels, bioplastics, and industrial enzymes. |
| 5 | Saudi Arabia | US$ XX.X Mn | XX.X% | Saudi Arabia is actively diversifying its economy through Vision 2030, investing in industrial biotechnology to reduce reliance on oil and develop sustainable industries. Focus areas include bio-based chemicals and advanced materials production. |
Countries Covered (26)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, Netherlands, France, United Kingdom, Italy, Spain, Russia, Rest of Europe, China, Japan, India, South Korea, Taiwan, Australia, Malaysia, Rest of Asia Pacific, Saudi Arabia, South Africa, United Arab Emirates, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Novozymes A/S | XX.X% | Focus on innovation in biological solutions to improve industrial processes and develop sustainable products across various sectors. | — | — | Industrial EnzymesProbioticsBiofuels enzymes+1 |
| 2 | Corbion | XX.X% | Leverage expertise in lactic acid and its derivatives to offer sustainable preservation, functionality, and nutrition solutions. | — | — | Lactic acidLactic acid derivativesEmulsifiers+1 |
| 3 | Roquette Frères | XX.X% | Deliver plant-based ingredients and pharmaceutical excipients to meet global nutrition, health, and sustainability demands. | — | — | Pea proteinDextroseMaltitol+1 |
| 4 | POET | XX.X% | Innovate and scale sustainable bioproducts from agricultural waste, focusing on renewable fuels and co-products. | — | — | BioethanolRenewable dieselCO2+1 |
| 5 | Gevo | XX.X% | Commercialize a fully integrated process to convert renewable energy and low-carbon raw materials into net-zero carbon fuels and chemicals. | — | — | Sustainable Aviation FuelRenewable GasolineRenewable Diesel+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Novozymes A/S, Corbion, Roquette Frères, POET, Gevo, LanzaTech Global, Inc., Amyris, Genomatica, Codexis, AvantGuard, Danimer Scientific, Origin Materials, Verbio Vereinigte BioEnergie AG, Aemetis, Green Plains Inc., Global Bioenergies, Yield10 Bioscience, Targray Technology International, Solugen, Circa Group
The global Industrial Biotechnology market features a competitive landscape led by Novozymes A/S, Corbion, Roquette Frères, POET, Gevo, and LanzaTech Global, Inc., among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
Novozymes A/S
Corbion
Roquette Frères
POET
Gevo
LanzaTech Global, Inc.
Amyris
Genomatica
Codexis
AvantGuard
Danimer Scientific
Origin Materials
Verbio Vereinigte BioEnergie AG
Aemetis
Green Plains Inc.
Global Bioenergies
Yield10 Bioscience
Targray Technology International
Solugen
Circa Group
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Bio-Polymer Breakthrough: Major Chemical Firm Unveils Sustainable Plastic Alternative
A leading chemical manufacturer has introduced a novel bio-based polyethylene terephthalate (PET) precursor, significantly reducing reliance on fossil fuels and offering a lower carbon footprint for packaging and textiles. This innovation leverages advanced microbial fermentation processes.
Industrial Biotech Startup Partners with Global Manufacturer to Scale Bio-Fibers Production
A cutting-edge biotechnology firm specializing in sustainable materials has inked a strategic partnership with a global textile manufacturer to commercialize its high-performance bio-fibers. The collaboration aims to scale production significantly and penetrate new markets.
Leading Bio-Chemical Producer Secures US$ XX.X Investment for New European Biorefinery
A prominent company in the bio-based chemicals sector has successfully closed a Series C funding round, securing US$ XX.X to finance the construction of its next-generation biorefinery in Northern Europe. The facility will focus on converting agricultural waste into high-value specialty chemicals.
Global Specialty Chemicals Giant Acquires Enzyme Engineering Innovator
A major specialty chemicals conglomerate has announced the acquisition of a startup renowned for its proprietary enzyme engineering platform, aiming to integrate advanced biocatalytic solutions into its existing manufacturing processes. This move is expected to enhance efficiency and sustainability across its product portfolio.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $45.0 Bn |
| Market Size (Forecast) | $97.2 Bn |
| CAGR | 8.0% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 26 Countries |
| Segments Covered | 6 Segments, 39 Sub-segments |
| Companies Profiled | 31 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the Industrial Biotechnology Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
VP, Corporate Strategy
Industrial manufacturing company
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Director, Investment Research
Private equity firm
“We now use these reports in every planning cycle. The regional granularity, and the same numbers across the report, the dashboard and the Excel, save our team real time.”
Head of Market Intelligence
Specialty chemicals company
Frequently Asked Questions
Common questions about this report and our research
The Industrial Biotechnology market is estimated at $45.0 Bn in 2025. It is forecast to reach $97.2 Bn in 2035, indicating substantial growth over the next decade. These figures reflect the increasing adoption of bio-based solutions across various industries.
The Industrial Biotechnology market is forecast to grow at a CAGR of 8.0% from 2025 to 2035. This growth rate is driven by factors such as environmental regulations, consumer demand for sustainable products, and ongoing technological advancements in bioprocesses and materials.
The market is segmented by Type (e.g., Biofuels, Biochemicals), Technology (e.g., Fermentation Technology, Biocatalysis & Enzyme Engineering), Application (e.g., Chemicals & Materials, Food & Beverages), Source (e.g., Agricultural Feedstocks, Waste Streams), End-User (e.g., Chemical & Petrochemical Industry, Food & Beverage Industry), and Process (e.g., Microbial Fermentation, Enzymatic Biotransformation).
Leading companies in the Industrial Biotechnology market include Novozymes A/S, Corbion, Roquette Frères, POET, Gevo, LanzaTech Global, Inc., Amyris, Genomatica, Codexis, AvantGuard, Danimer Scientific, and Origin Materials. These companies are involved in various aspects of bio-based production and innovation.
The Industrial Biotechnology market report covers global market analysis across key regions and countries. It provides segmentation by product type, application, and end-use industry. The report includes market sizing and forecasts from 2025 to 2035, offering insights into market dynamics and competitive landscape.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
Carbon Utilization Biotechnology Market
$312.0 Mn in 2025 · 24.5% CAGR
Future Circular Biotechnology Market
$518.0 Mn in 2025 · 20.7% CAGR
Industrial CO2 Fermentation Market
$386.6 Mn in 2025 · 24.6% CAGR
Industrial Enzymes Market
$5.3 Bn in 2025 · 10.4% CAGR
Marine Biotechnology Market
$8.6 Bn in 2025 · 15.7% CAGR
Biodegradable Industrial Materials Market
$6.5 Bn in 2025 · 14.9% CAGR
Industrial Adhesives Market
$58.9 Bn in 2025 · 5.7% CAGR
Industrial Biofiltration Systems Market
$1.7 Bn in 2025 · 6.5% CAGR